Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by steadfaston Dec 05, 2014 7:56pm

210 Views

Post# 23201708

RE:RE:Stem-Cell Breakthrough in Treatment of Diabetes

nopoo
The Harvard NR states "so problem one is replacing beta cells and these cells are
suitable for that kind of replacement - combination with some kind of immune protection".

SERTOLIN may be the answer.
The Cell pouch may be the answer.

Yes, I agree this is a difficult stock to be in and hold, particularly when Dr. Tolekis has
never replied to my letter of May 10, 2014. I did get a very kind reply from Ray Matthews advising that Philip will be happy to respond to me directly. Makes me question
Dr T's peoples skills!!! However, if the efficacy results are good and the stock takes off,
I will be happy.

Bullboard Posts

How one company is disrupting PoC testing